Mechanism
Tumor-infiltrating lymphocytes (TILs)
Assets acting on this target.
- Class
- Autologous tumor-infiltrating lymphocyte cell therapy
- Notes
- audit finding #581 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT07444437
Mechanism
Assets acting on this target.
1 of 1 assets